ALTCAR.CD30 cells: Clinical Trials

1 trial of ALTCAR.CD30 cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow ALTCAR.CD30 cells: new trials by email Literature Review of ALTCAR.CD30 cells trials Research Report on ALTCAR.CD30 cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
ATLCAR.CD30.CCR4 cells, ALTCAR.CD30 cells, Bendamustine - Lymphoma, Immune System Diseases
Phase 1Active not recruitingUNC Lineberger Comprehensive Cancer Center432018-10-292026-06-12

Conditions studied

Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Lymphomatoid Papulosis (1)  ·  Lymphoproliferative Disorders (1)  ·  Mycosis Fungoides (1)  ·  Neoplasms (1)  ·  Sezary Syndrome (1)

Sponsors

UNC Lineberger Comprehensive Cancer Center (1)

Countries

United States (1)

Top investigators

Natalie Grover, MD (1)

NIH funding

R01CA247497 (1)